Whether breastfeeding protects
|
|
|
- Theresa Hamilton
- 9 years ago
- Views:
Transcription
1 Clinical Care/Nutrition/Education O R I G I N A L A R T I C L E Influence of Breastfeeding on Obesity and Type 2 Diabetes Risk Factors in Latino Youth With a Family History of Type 2 Diabetes JAIMIE N. DAVIS, PHD 1 MARC J. WEIGENSBERG, MD 1,2 GABRIEL Q. SHAIBI, PHD 3 NOE C. CRESPO, MPH 1 LOUISE A. KELLY, PHD 1 CHRISTIANNE J. LANE, PHD 1 MICHAEL I. GORAN, PHD 1 OBJECTIVE To determine whether breastfeeding is related to total adiposity, regional adiposity, and glucose and insulin dynamics in overweight Latino youth throughout puberty. RESEARCH DESIGN AND METHODS The relation between breastfeeding and diabetes risk was determined in 240 overweight (BMI 85th percentile) Latino children (aged 8 13 years) with a positive family history of type 2 diabetes. Children were examined at baseline (Tanner pubertal stage 1) and for 2 more years as they advanced in pubertal maturation. Children were divided into the following categories: never breastfed (n 102), breastfed months (n 61), breastfed months (n 24), and breastfed 12 months (n 53). Tanner pubertal stage was determined by physical examination. Visceral and subcutaneous abdominal fat were determined by magnetic resonance imagining, and total body fat, total lean tissue mass, and percent body fat were measured by dual-energy X-ray absorptiometry. Fasting and postchallenge glucose were assessed with a 2-h oral glucose tolerance test. Insulin sensitivity (SI), acute insulin response (AIR), and disposition index ([DI] an index of -cell function) were measured by frequently sampled intravenous glucose tolerance test and minimal modeling. Data were analyzed using linear mixed-effects modeling. RESULTS There were no significant effects of breastfeeding categories on adiposity (i.e., total fat mass, total lean tissue mass, percent body fat), fat distribution (visceral and subcutaneous abdominal fat), fasting glucose or 2-h glucose, or insulin dynamics (SI, AIR, and DI) at Tanner pubertal stage 1 or on changes in these variables over pubertal transitions in overweight Latino youth. CONCLUSIONS In this population of high-risk Latino youth, there were no significant protective effects of breastfeeding on adiposity or type 2 diabetes risk factors at Tanner pubertal stage 1 or across advances in maturation. Diabetes Care 30: , 2007 From the 1 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; the 2 Department of Pediatrics, LAC USC Medical Center, Los Angeles, California; and the 3 College of Nursing and Healthcare Innovation, Arizona State University, Phoenix, Arizona. Address correspondence and reprint requests to Michael I. Goran, 2250 Alcazar St., CSC 215, Los Angeles, CA [email protected]. Received for publication 27 September 2006 and accepted in revised form 2 January Published ahead of print at on 2 February DOI: /dc Abbreviations: AIR, acute insulin response; DEXA, dual-energy X-ray absorptiometry; DI, disposition index; FSIVGT, frequently sampled intravenous glucose tolerance; GDM, gestational diabetes mellitus; IGT, impaired glucose tolerance; MRI, magnetic resonance imaging; OGTT, oral glucose tolerance test; SI, insulin sensitivity. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances; 2007 by the American Diabetes Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Whether breastfeeding protects against obesity later in life is a controversial topic in literature. Some investigators have shown that breastfeeding has protective effects against childhood obesity (1 5), while others have not observed an association (6 8). Moreover, the protective effect of breastfeeding may vary according to ethnicity (6,9,10). This debate may be hampered because of prior study designs in that the majority of studies have used either global measures of adiposity such as BMI or less accurate estimates of body composition such as skinfolds. To date, few studies have examined the effects of breastfeeding on general adiposity using dual-energy X-ray absorptiometry (DEXA) (11 13), and no study has examined the effects of breastfeeding on fat distribution using magnetic resonance imaging (MRI). Moreover, no previous study has assessed the protective breastfeeding effects on adiposity or risk factors for type 2 diabetes across pubertal transition from Tanner stage 1 to 5. Recently, several investigators have demonstrated that breastfeeding was also protective against type 2 diabetes in Caucasian children (14) and adults (15) and in Pima Indian children and adults (16). Type 2 diabetes is no longer thought of as an adult disease and is occurring at increasing rates in younger and minority populations (17,18). We have previously shown that over 30% of overweight Latino children with a positive family history of type 2 diabetes exhibit impaired glucose tolerance (IGT) (19). We have found that Latino children are more insulin resistant than Caucasian children, independent of body fat content (20). Although we recently showed that insulin sensitivity (SI) in Latino children declines over time, this decline is unrelated to changes in body fat or maturation. However, we found that the acute insulin response to glucose worsens in advanced Tanner stages, thus indicating the diminishing capacity of -cells to respond to the decline in SI as children mature (21). These results suggest that pubertal transi- 784 DIABETES CARE, VOLUME 30, NUMBER 4, APRIL 2007
2 tion may be an additional risk factor for the development of pediatric type 2 diabetes. Despite these alarming findings in overweight Latino youth, the effects of breastfeeding on type 2 diabetes risk factors in this population have not been examined. Morever, no study has examined the protective effects of breastfeeding on type 2 diabetes risk factors using precise measures of SI, e.g., frequently sampled intravenous glucose tolerance (FSIVGT), in prepubescent children or across pubertal transitions. Therefore, the purpose of this study was to assess the relation between breastfeeding, adiposity, and type 2 diabetes risk factors using precise measures (i.e., DEXA, MRI, and FSIVGT tests) at baseline (Tanner pubertal stage 1) and across puberty transition in overweight Latino youth with a positive family history of type 2 diabetes. We hypothesized that breastfeeding for longer durations would have protective effects on baseline and changes in adiposity and type 2 diabetes risk factors in prepubescent Latino children and across maturation. RESEARCH DESIGN AND METHODS Subjects The design, data collection procedures, and findings of the University of Southern California longitudinal SOLAR (Study of Latino Adolescents at Risk for Diabetes) has been described in detail elsewhere (19,22), but neither analysis of breastfeeding status nor its relationship with adiposity and type 2 diabetes risk factors has been published. Although we intend to follow this cohort throughout puberty (i.e., up to 18 years of age), for the present study, complete longitudinal data are only available for the first 3 years. From the 240 participants (8 13 years of age) at year 1, 170 participants were measured at year 2 and 150 participants at year 3. Physical characteristics (i.e., age, weight, height, BMI, BMI percentile) are available for the entire sample in all three yearly visits, body composition (i.e., total fat mass, total lean tissue) and fasting and 2-h glucose data are available for 85% of the original sample at all visits, and fat distribution (i.e., subcutaneous and visceral fat stores) and insulin dynamics are available for 70% of the original sample at all visits. Children were categorized as follows: 1) 8 13 years of age, 2) BMI 85th percentile for age and sex based on the Centers for Disease Control and Prevention guidelines (23), 3) Latino ancestry (all four grandparents were of Latino origin as determined by parental self-report), and 4) family history of type 2 diabetes in at least one parent, sibling, or grandparent. None of the children were taking medications known to affect body composition, had syndromes or diseases known to affect body composition or fat distribution, or had any major illness since birth. The institutional review board of the University of Southern California approved this study. Informed consent and assent were obtained from both the parents and the child before testing commenced. All procedures were carried out at the University of Southern California General Clinical Research Center. Breastfeeding status A detailed medical history and physical examination was performed by a licensed pediatric care provider. Tanner pubertal staging was based on breast stage in girls and pubic hair stage in boys (24,25). Parental interview at year 1 detailed the family history of diabetes, gestational diabetes mellitus ([GDM] of mother related to child in this study), child s birth weight, whether the mother breastfed, and length of breastfeeding. Breastfeeding status was analyzed as both a continuous variable and as a categorical variable (i.e., never breastfed, breastfed months, breastfed months, and breastfed 12 months). Body composition and fat distribution Height and weight were measured using a beam medical scale and wall-mounted stadiometer to the nearest 0.1 kg and 0.1 cm, respectively, and the average of the two measurements was used for analysis. BMI and BMI percentiles for age and sex were determined using EpiInfo 2000, version 1.1 (Centers for Disease Control and Prevention, Atlanta, GA). Body composition (total fat mass and total lean tissue mass) was assessed with a total body DEXA scan, using a Hologic QDR 4500W (Hologic, Bedford, MA). Visceral and subcutaneous abdominal fat were measured by MRI at the Los Angeles County/ University of Southern California Imaging Science Center using a 1.5 Signal LX- Ecospeed I.5 Tesla magnet (General Electric) and a single slice at the level of the umbilicus. Davis and Associates Insulin and glucose dynamics After an overnight fast, a 2-h oral glucose tolerance test (OGTT) was conducted using a dose of 1.75 g glucose/kg body wt (to a maximum of 75 g). Blood was sampled and assayed for glucose and insulin at 5 min (fasting state) and 120 min (2 h) relative to glucose ingestion. The OGTT results were used to determine normal glucose tolerance (2-h glucose 140 mg/dl) or impaired glucose tolerance ([IGT] 2-h glucose 140 and 200 mg/dl) using criteria proposed by the American Diabetes Association (18). Approximately 1 2 weeks after the OGTT visit, children were admitted for an overnight visit for determination of body composition and insulin dynamics, i.e., SI, insulin area under the curve (acute insulin response [AIR]), and the disposition index ([DI] a product of AIR and SI and a measure of pancreatic -cell function). The children were served dinner and an evening snack. Only water and noncaloric and noncaffeinated beverages were allowed between 8:00 P.M. and the time of the testing the following morning, when an FSIVGT test was performed to determine SI, AIR, and DI. A topical anesthetic (EMLA cream; Aztrozeneca, Wilmington, DE) was applied to the antecubital area of both arms, and an hour later a flexible intravenous catheter was inserted into both arms. Two fasting blood samples, at 15 and 5 min, were obtained for determination of basal glucose and insulin values. At time zero, glucose (25% dextrose; 0.3 g/kg body wt) was administered intravenously. Blood samples were then collected at the following time points: 2, 4, 8, 19, 22, 30, 40, 50, 70, 100, and 180 min. Insulin (0.02 units/kg body wt) (Humulin R [regular insulin for human subjects]; Eli Lilly, Indianapolis, IN) was injected intravenously at 20 min. Plasma was analyzed for glucose and insulin, and values were entered into the Minmod Millennium 2003 computer program (version 5.16; Richard N. Bergman, University of Southern California) for determination of SI, AIR, and DI. Glucose from the OGTT was analyzed on a Dimension Clinical Chemistry system using an in vitro hexokinase method (Dade Behring, Deerfield, IL). Blood samples from the FSIVGT test were centrifuged immediately to obtain plasma, and aliquots were frozen at 70 C until assayed. Glucose was assayed in duplicate on a Yellow Springs Instrument 2700 Analyzer (Yellow Springs Instrument; Yellow Springs, OH) using the glucose DIABETES CARE, VOLUME 30, NUMBER 4, APRIL
3 Breastfeeding influence on type 2 diabetes oxidase method. Insulin was assayed in duplicate using a specific human insulin ELISA kit from Linco (St. Charles, MO). Statistical procedures Dependent variables that were not normally distributed, i.e., BMI percentile, total fat, total lean tissue mass, visceral and subcutaneous abdominal fat, SI, DI, and AIR, were log transformed. 2 was used to assess differences in descriptive categorical data (i.e., sex, GDM), and ANOVA was used to assess differences in descriptive continuous data (i.e., birth weight and age) at baseline (i.e., Tanner pubertal stage 1) between breastfeeding categories. Linear mixed-effects modeling was used to evaluate the effects of breastfeeding at baseline and on longitudinal changes in total fat, total lean tissue, percent body fat, visceral and subcutaneous abdominal fat, fasting and 2-h glucose, and insulin dynamics (SI, AIR, and DI) over puberty transition from Tanner pubertal stage 1 to 5. Breastfeeding status was analyzed as both a continuous variable and as a categorical variable (i.e., never breastfed, breastfed months, breastfed months, and breastfed 12 months). Visual examinations of the dependent variables (transformed and nontransformed) over Tanner stage were explored to allow for the possibility of nonlinear effects. If nonlinear, than a quadratic Tanner stage was included in the model. The following covariates were entered into the model: birth weight, GDM, total body fat and lean tissue mass, changes in body fat and lean tissue mass (when adiposity and type 2 diabetes risk factors were dependent variables, change in body composition was defined as the absolute difference between the first and last waves of measurement) and SI (when AIR was a dependent variable only). The model was run with and without entering baseline and changes in body composition as covariates. By modeling across Tanner pubertal stage, we were able to test whether breastfeeding status affects adiposity and type 2 diabetes risk factors at prepubescent stages (i.e., Tanner stage 1) and across pubertal transition (transition from Tanner stage 1 to 5). When using linear mixed-effects modeling, results included an intercept level (i.e., Tanner stage 1) of the dependent variable, a rate of change over Tanner stages in the dependent variable, and an interaction effect of Tanner stage and breastfeeding category on the dependent variable. In addition, the moderator effect of GDM and birth weight on the relationship between breastfeeding and the outcome variable at baseline and across puberty was entered into the model (i.e., GDM and body weight breastfeeding status Tanner). The stratified moderator effect with breastfeeding and outcomes variables within different levels of birth weight (divided by median split) and GDM (yes vs. no) was also entered into the model. For all models, Tanner was centered at baseline Tanner 1 and dependent variables were centered at their mean values for ease of interpretation. All analyses were performed using SPSS version 13.0 (SPSS, Chicago, IL), with significance set at P RESULTS For year 1 (n 240), the percentage of participants in Tanner stages 1, 2, 3, 4, and 5 were 41, 28, 9, 13, and 9%, respectively. For year 2 (n 170), the percentage of participants in Tanner stages 1, 2, 3, 4, and 5 were 22, 28, 11, 23, and 16%. For year 3 (n 150) they were 12, 23, 13, 25, and 27%. Physical and metabolic characteristics of breastfeeding categories (i.e., subjects who were never breastfed, breastfed months, breastfed months, and breastfed 12 months) at Tanner pubertal stage 1 are displayed in Table 1. The presence of GDM was significantly different between breastfeeding categories (P 0.05). Visual examinations of the dependent variables (transformed and nontransformed) over Tanner stages were all linear, except for transformed AIR; therefore, the quadratic Tanner stage was included in the model when AIR was the dependent variable. Using linear mixed-effects modeling with covariates GDM, birth weight, and sex, there were no significant effects of breastfeeding on general adiposity (i.e., BMI, BMI percentile, total fat, total lean tissue mass, percent body fat), body fat distribution (i.e., visceral or subcutaneous adipose tissue), fasting or 2-h glucose, or insulin dynamics (i.e., SI, DI, AIR) at Tanner pubertal stage 1 or on longitudinal changes in these variables across pubertal (i.e., Tanner stage) transitions (P 0.20; data not shown). These results remained nonsignificant once baseline and changes in body composition parameters were entered into the model as covariates. When examining the moderating effect of GDM and birth weight, we found that there was a significant interaction effect of birth weight and breastfeeding status on DI and AIR across puberty (P 0.05), although not at baseline. There was also a significant interaction of GDM and breastfeeding status on subcutaneous abdominal tissue at baseline and across puberty (P 0.05). However, the stratified analyses with GDM (yes vs. no GDM status) and with birth weight (divided by a median split) on the relationship between breastfeeding and the outcome variable did not produce differential effects. We also ran the analyses with a variety of different breastfeeding variables: breastfeeding as a continuous variable, a dichotomous breastfeeding category (i.e., never breastfed vs. ever breastfed), shorter duration of breastfeeding (i.e., breastfed months and months), and a combination of breastfed months and 12 months into one category. For all the different breastfeeding variables assessed, the same nonsignificant findings persisted (P 0.20; data not shown). CONCLUSIONS The major findings of this study indicated that there are no significant overall protective effects of breastfeeding on general adiposity, fat distribution, or type 2 diabetes risk factors in overweight Latino youth with a positive family history of type 2 diabetes. Few studies have examined the relationship of breastfeeding and general adiposity using DEXA (11,12), and none have assessed the relationship between breastfeeding and fat distribution using MRI. To our knowledge, this is the first study to examine the relationship between breastfeeding status and insulin dynamics using precise measures of SI. We are also the first to look at the protective effects of breastfeeding on longitudinal changes in adiposity and type 2 diabetes risk factors across maturation stages. Although numerous studies have examined the influence of breastfeeding on type 1 diabetes (26,27), few have looked at the association between breastfeeding and type 2 diabetes (14,16). Most notably, the study by Pettitt et al. (16) on 720 Pima Indians years of age found that exclusive breastfeeding for at least 2 months was associated with a lower rate of type 2 diabetes, as measured by OGTT. Young et al. (14) conducted a casecontrol study of 138 native Canadian children years of age and determined that prolonged breastfeeding ( 6 months) was a strong protector against the risk of type 2 diabetes, as determined with American Diabetes Association fasting blood glucose criteria. Two other studies 786 DIABETES CARE, VOLUME 30, NUMBER 4, APRIL 2007
4 Table 1 Physical and metabolic characteristics of breastfeeding categories at Tanner pubertal stage 1 at all visits (baseline) Davis and Associates Never breastfed Breastfed months Breastfed months Breastfed 12 months n (total) Male sex 48 (75.0) 39 (83.0) 8 (100) 26 (74.3) GDM 23 (35.9) 6 (12.8) 1 (12.5) 12 (34.3) Birth weight (kg) Age (years) BMI (kg/m 2 ) BMI percentile n Total fat (kg) Total lean tissue mass (kg) n Subcutaneous abdominal fat (cm 2 ) Visceral abdominal fat (cm 2 ) n (n 32) Fasting glucose ( U/ml) h glucose ( U/ml) n SI ( 10 4 min 1 / U/ml) AIR ( U/ml 10 min) 1, , , , , DI ( 10 4 /min 1 ) 3, , , , , , , Data are n, n (%), and mean SD. Statistical analyses were performed using log-transformed data (i.e., BMI percentile, total fat, total lean tissue mass, visceral, subcutaneous adipose tissue, SI, DI, and AIR), but data are shown as nontransformed values for ease of interpretation. Differences in sex and GDM status were assessed using 2, while ANOVA assessed differences in birth weight and age between breastfeeding groups. GDM status was significantly different between breastfeeding groups (P 0.05). Using mixed modeling after adjusting for covariates (i.e., GDM, age, sex, and body composition) as appropriate and AIR (with dependent variable SI only), there were no significant differences in adiposity or metabolic parameters between breastfeeding categories at Tanner pubertal stage 1 or in change in these variables across maturation. have shown an inverse association between breastfeeding and fasting glucose levels in young children (28) and 2-h glucose in adults (15). In two large prospective cohorts of young and middle-aged women, duration of lactation was inversely related with the risk of type 2 diabetes, independent of other diabetes risk factors including BMI, diet, exercise, and smoking status (29). To date, no study has assessed the protective effects of breastfeeding on type 2 diabetes risk factors using precise measures of SI, e.g., FSIVGT test. In addition, many of these studies have controlled for more crude measures of adiposity, such as weight or BMI (14,16,29). Even though we ran the analyses with and without controlling for total fat and total lean tissue, which we have previously shown (30,31) to influence glucose and insulin dynamics, one could argue that excess weight or adiposity is the mechanism in which breastfeeding affects type 2 diabetes risk factors; this suggests that investigators should examine the effects that breastfeeding has on both obesity and type 2 diabetes risk factors with and without controlling for adiposity. In this study, breastfeeding was not associated with type 2 diabetes risk factors, as measured with OGTT or an FSIVGT test, with and without controlling for adiposity measures at baseline or across pubertal transitions. Whether breastfeeding protects against childhood obesity remains controversial, but there appears to be more research supporting the inverse association of breastfeeding status and length of breastfeeding with childhood obesity (1,4,5). A very large meta-analysis of 61 studies showed that initial breastfeeding protects against obesity, as measured by BMI later in life (5). Twenty-eight of these studies showed that breastfeeding was associated with a reduced risk of obesity compared with formula feeding (odds ratio 0.87 [95% CI ]). However, in our study, breastfeeding was not protective against childhood obesity using BMI measures. To date, many investigators have used skinfolds to assess adiposity, and few studies have evaluated the relationship of breastfeeding status to more precise measures of adiposity. A study of 563 New Zealand children followed from birth to 7 years of age showed no significant differences in body fatness (i.e., skinfolds) between infants exclusively breastfed and formula fed for the first 3 months of life (32). A study by Tulldahl et al. (11) found that 781 Swedish adolescents who were exclusively breastfed for 3 months tended to have lower skinfolds than those who were not breastfed or breastfed as infants for 3 months, but there was no significant difference in body fat measured by DEXA in a subgroup of these adolescents (n 194) between breastfeeding categories (11). A recent study by Burdette et al. (12) showed that breastfeeding was not associated with adiposity as measured with DEXA in 313 children at age 5 years. In this study, breastfeeding status was neither associated with total fat, percent body fat, or total lean tissue mass as measured by DEXA or with fat distribution as measured by MRI. In addition, a longer duration of breastfeeding also appears to be protective against childhood obesity (33,34). Most notably, von Kries et al. (33) found a clear dose response for the duration of breastfeeding on the prevalence of obesity in German children, aged 5 6 years; the prevalence was 3.8% for 2 months of exclusive breastfeeding, 2.3% for 3 5 months, 1.7% for 6 12 months, and 0.8% for 12 months. In this study, DIABETES CARE, VOLUME 30, NUMBER 4, APRIL
5 Breastfeeding influence on type 2 diabetes the duration of breastfeeding was not related to a significant reduction in general adiposity or fat distribution. Other breastfeeding duration categories were assessed, i.e., never breastfed versus ever breastfed, months, and months, but no association to adiposity measures were noted. Only three previous studies have examined the effects of breastfeeding on obesity among Latinos, and two of them found no association between breastfeeding and childhood obesity. Grummer- Strawn et al. (10) found that duration of breastfeeding showed a protective relationship with the risk of overweight only among non-hispanic whites, whereas length of breastfeeding was not protective against risk of overweight in non- Hispanic African Americans or Hispanics. Zive et al. (6) found that neither breastfeeding status nor the duration of breastfeeding was correlated with indicators of adiposity (i.e., sum of seven skinfolds) in 331 (43% white and 57% Mexican American) children 3 or 4 years of age; however, obesity was not common in this sample. In contrast, a study by Hediger et al. (9) of 2,685 children, 3 5 years of age and 30% Mexican-American, showed that subjects who were breastfed had a reduced risk of being at risk of overweight (85 94th BMI percentiles) compared with never-breastfed subjects, but there was no reduced risk of being overweight ( 95th BMI percentile) between breastfeeding categories. These results indicate that ethnic disparities may exist in the relationship between breastfeeding and obesity protection. Contrary to our hypotheses, we did not note any significant relations between breastfeeding and adiposity or type 2 diabetes risk factors at prepubescent stages or throughout puberty. One explanation for the null findings is that breastfeeding rates are lower in overweight and obese mothers (9), suggesting that familial dietary habits and activity patterns and genetics may supersede breastfeeding as a risk factor for childhood obesity and type 2 diabetes. The socioeconomic status also plays a role in promoting childhood obesity (35); however, all participants in this study are from low-income areas. Another explanation for the null findings is that our sample is very homogeneous due to the strict inclusion criteria, and more differences in adiposity and type 2 diabetes risk factors between breastfeeding groups may have been apparent if normal-weight Latino children or other ethnicities were included. However, we have shown that the degree of overweight and fat distribution (i.e., visceral fat measured with MRI) is not a predictor of IGT and that IGT is more associated with poor -cell function and insulin resistance (22). Thus, within this population of overweight Latino children with a family history of type 2 diabetes, some are more insulin resistant and more likely to develop pre-diabetes while others are not. In this cohort, we wanted to explore which environmental factors, i.e., in terms of breastfeeding status, are influencing adiposity and type 2 diabetes risk factors. The homogeneity of this particular sample gives us the unique opportunity to assess factors influencing progression of type 2 diabetes, independent of large variations in adiposity, in a very at-risk population. Several limitations of our study should be considered. Breastfeeding information was obtained retrospectively from the mother at the year 1 visit, which would have been 8 13 years after the birth of the child, and is therefore subject to recall bias. However, other investigators have shown maternal recall of infantfeeding data to be a valid and reliable measure (36,37), even after 20 years (38). Another limitation is that we did not collect child-feeding data, such as introduction of solids and concurrent formula feeding. This supplementation of solids or formula may negate or mask the potential beneficial effects of the breastfeeding. Yet, some researchers have shown that these child-feeding factors are not or only marginally related to childhood obesity (4,9,12) and that breastfeeding appears to play a more integral role. Another limitation is the moderating effect of GDM and birth weight on certain outcome variables at baseline and across puberty. The significant moderating effects of GDM and birth weight could have altered the relationship between breastfeeding and certain outcome variables (i.e., DI, AIR, and subcutaneous visceral fat). However, when we ran the stratified analyses with GDM (yes vs. no GDM status) and birth weight (divided by a median split), we found that breastfeeding did not have a differential effect on the outcomes variables; thus we feel that including GDM and birth weight as covariates in our analyses is acceptable. We also did not collect the rate of weight gain during infancy. An additional limitation is that the current study used a relatively small sample size of children (n 240) compared with prior epidemiological studies. When breastfeeding was broken down into categories, there were only eight subjects who had been breastfed months. However, when breastfeeding was run as a continuous variable and as shorter and longer duration categories, identical nonsignificant results were found. The limitation of a small sample size is somewhat offset by use of precise measures of body composition (DEXA and MRI), as well as glucose and insulin dynamics (OGTT and FSIVGT test), control of various covariates, and the longitudinal design. In conclusion, to our knowledge, this is the first study to examine the influence of breastfeeding on detailed and precise measures of body composition, fat distribution, and insulin dynamics in overweight Latino youth at prepubescent stages and longitudinal changes across puberty. Even though we did not observe any protective effects of breastfeeding on measures of adiposity and type 2 diabetes, continued longitudinal analyses using more precise and valid measures are warranted, especially in populations that are extremely susceptible to becoming obese and developing type 2 diabetes. Acknowledgments This study was supported by National Institutes of Health Grant R01 DK 59211, General Clinic Research Center and National Center for Research Resources Grant M01 RR 00043, and the American Diabetes Association Mentor-Based Postdoctoral Fellowship 2005 (awarded to M.I.G.). We are grateful to the project managers, Quintilia Avila and Christina Ayala, and to the nurses and nutrition staff at the University of Southern California General Clinic Research Center. Finally, we express our gratitude to the children and their families for making this study possible. References 1. Arenz S, Ruckerl R, Koletzko B, von Kries R: Breast-feeding and childhood obesity: a systematic review. Int J Obes Relat Metab Disord 28: , Kramer MS: Do breast-feeding and delayed introduction of solid foods protect against subsequent obesity? J Pediatr 98: , Bergmann KE, Bergmann RL, von Kries R, Bohm O, Richter R, Dudenhausen JW, Wahn U: Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding. Int J Obes Relat Metab Disord 27: , Gillman MW, Rifas-Shiman SL, Camargo CA Jr, Berkey CS, Frazier AL, Rockett HR, 788 DIABETES CARE, VOLUME 30, NUMBER 4, APRIL 2007
6 Field AE, Colditz GA: Risk of overweight among adolescents who were breastfed as infants. JAMA 285: , Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG: Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics 115: , Zive MM, McKay H, Frank-Spohrer GC, Broyles SL, Nelson JA, Nader PR: Infantfeeding practices and adiposity in 4-y-old Anglo- and Mexican-Americans. Am J Clin Nutr 55: , Baranowski T, Bryan GT, Rassin DK, Harrison JA, Henske JC: Ethnicity, infantfeeding practices, and childhood adiposity. J Dev Behav Pediatr 11: , Li L, Parsons TJ, Power C: Breast feeding and obesity in childhood: cross sectional study. BMJ 327: , Hediger ML, Overpeck MD, Kuczmarski RJ, Ruan WJ: Association between infant breastfeeding and overweight in young children. JAMA 285: , Grummer-Strawn LM, Mei Z: Does breastfeeding protect against pediatric overweight?: Analysis of longitudinal data from the Centers for Disease Control and Prevention Pediatric Nutrition Surveillance System. Pediatrics 113:e81 86, Tulldahl J, Pettersson K, Andersson SW, Hulthen L: Mode of infant feeding and achieved growth in adolescence: early feeding patterns in relation to growth and body composition in adolescence. Obes Res 7: , Burdette HL, Whitaker RC, Hall WC, Daniels SR: Breastfeeding, introduction of complementary foods, and adiposity at 5 y of age. Am J Clin Nutr 83: , Butte NF, Wong WW, Hopkinson JM, Smith EO, Ellis KJ: Infant feeding mode affects early growth and body composition. Pediatrics 106: , Young TK, Martens PJ, Taback SP, Sellers EA, Dean HJ, Cheang M, Flett B: Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native Canadians. Arch Pediatr Adolesc Med 156: , Ravelli AC, van der Meulen JH, Osmond C, Barker DJ, Bleker OP: Infant feeding and adult glucose tolerance, lipid profile, blood pressure, and obesity. Arch Dis Child 82: , Pettitt DJ, Forman MR, Hanson RL, Knowler WC, Bennett PH: Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet 350: , Dean HJ, Mundy RL, Moffatt M: Noninsulin-dependent diabetes mellitus in Indian children in Manitoba. CMAJ 147: 52 57, American Diabetes Association: Type 2 diabetes in children and adolescents. Pediatrics 105: , Cruz ML, Weigensberg MJ, Huang T, Ball GDC, Shaibi GQ, Goran MI: The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89: , Goran M, Bergman R, Cruz M, Watanabe R: Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25: , Goran MI, Shaibi GQ, Weigensberg MJ, Davis JN, Cruz ML: Deterioration of insulin sensitivity and beta-cell function in overweight Hispanic children during pubertal transition: a longitudinal assessment. IJPO 3: , Goran MI, Bergman RN, Avila Q, Watkins M, Ball GD, Shaibi GQ, Weigensberg MJ, Cruz ML: Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 89: , Kuczmarski RJ, Ogden CL, Grummer- Strawn LM, Flega KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC Growth Charts: United States. In Advance Data., Centers for Disease Control and Prevention, National Center for Health Statistics, 4 December 2000 (NCHS publ. no. 314) 24. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 44: , Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13 23, Plagemann A, Harder T, Franke K, Kohlhoff R: Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care 25:16 22, Kimpimaki T, Erkkola M, Korhonen S, Kupila A, Virtanen SM, Ilonen J, Simell O, Knip M: Short-term exclusive breastfeeding predisposes young children with increased genetic risk of type I diabetes to Davis and Associates progressive beta-cell autoimmunity. Diabetologia 44:63 69, Baur LA, O Connor J, Pan DA, Kriketos AD, Storlien LH: The fatty acid composition of skeletal muscle membrane phospholipid: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 47: , Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB: Duration of lactation and incidence of type 2 diabetes. JAMA 294: , Gower BA, Nagy TR, Goran MI, Toth MJ, Poehlman ET: Fat distribution and plasma lipid-lipoprotein concentrations in pre- and postmenopausal women. Int J Obes Relat Metab Disord 22: , Cruz ML, Bergman RN, Goran MI: Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 25: , Birkbeck JA, Buckfield PM, Silva PA: Lack of long-term effect of the method of infant feeding on growth. Hum Nutr Clin Nutr 39:39 44, von Kries R, Koletzko B, Sauerwald T, von Mutius E, Barnert D, Grunert V, von Voss H: Breast feeding and obesity: cross sectional study. BMJ 319: , Liese AD, Hirsch T, von Mutius E, Keil U, Leupold W, Weiland SK: Inverse association of overweight and breast feeding in 9 to 10-y-old children in Germany. Int J Obes Relat Metab Disord 25: , Seidell JC: Epidemiology of obesity. Semin Vasc Med 5:3 14, Launer LJ, Forman MR, Hundt GL, Sarov B, Chang D, Berendes HW, Naggan L: Maternal recall of infant feeding events is accurate. J Epidemiol Community Health 46: , Holland B: The validity of retrospective breast-feeding-duration data: an illustrative analysis of data quality in the Malaysian Family Life Survey. Hum Biol 59: , Kark JD, Troya G, Friedlander Y, Slater PE, Stein Y: Validity of maternal reporting of breast feeding history and the association with blood lipids in 17 year olds in Jerusalem. J Epidemiol Community Health 38: , 1984 DIABETES CARE, VOLUME 30, NUMBER 4, APRIL
PLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by:[university of Southern California] [University of Southern California] On: 16 July 27 Access Details: [subscription number 773269524] Publisher: Informa Healthcare Informa
Obesity and Socioeconomic Status in Children and Adolescents: United States, 2005 2008
Obesity and Socioeconomic Status in Children and Adolescents: United States, 2005 2008 Cynthia L. Ogden, Ph.D.; Molly M. Lamb, Ph.D.; Margaret D. Carroll, M.S.P.H.; and Katherine M. Flegal, Ph.D. Key findings
Krystal Revai, MD, FAAP. Written Testimony. Breastfeeding as Primary Obesity Prevention. Obesity Prevention Initiative Act Public Hearings
Written Testimony Breastfeeding as Primary Obesity Prevention Obesity Prevention Initiative Act Public Hearings on behalf of the ILLINOIS CHAPTER, AMERICAN ACADEMY OF PEDIATRICS Submitted March 15, 2010
Diabetes Prevention in Latinos
Diabetes Prevention in Latinos Matthew O Brien, MD, MSc Assistant Professor of Medicine and Public Health Northwestern Feinberg School of Medicine Institute for Public Health and Medicine October 17, 2013
MATERNAL AND CHILD HEALTH BRIEF #2:
MATERNAL AND CHILD HEALTH BRIEF #2: OBESITY AMONG CHILDREN AND ADOLESCENTS SEPTEMBER 2012 OBESITY DEFINED Obesity and overweight are typically measured OVERVIEW in terms of Body Mass Index or BMI. BMI
Traditional View of Diabetes. Are children with type 1 diabetes obese: What can we do? 8/9/2012. Change in Traditional View of Diabetes
Are children with type 1 diabetes obese: What can we do? Traditional View of Diabetes Type 1 Diabetes ( T1DM) Onset Juvenile Lean Type 2 Diabetes ( T2DM) Onset Adult Obese QI Project Indrajit Majumdar
Body Mass Index Measurement in Schools BMI. Executive Summary
Body Mass Index Measurement in Schools BMI = BMI weight(kg) {height(m)} 2 Executive Summary Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion
Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO
Diabetes and Obesity in Children Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO Diabetes and Obesity in Children What is Diabetes? How are Diabetes and Obesity
Family History and Diabetes. Practical Genomics for the Public Health Professional
Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment
Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
THERE IS INCREASING clinical concern about excess
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(9):4061 4067 Printed in U.S.A. Copyright 2001 by The Endocrine Society Body Mass Index as a Measure of Adiposity in Children
The Influence of Infant Health on Adult Chronic Disease
The Influence of Infant Health on Adult Chronic Disease Womb to Tomb Dr Clare MacVicar Introduction Many diseases in adulthood are related to growth patterns during early life Maternal nutrition important
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
The National Survey of Children s Health 2011-2012 The Child
The National Survey of Children s 11-12 The Child The National Survey of Children s measures children s health status, their health care, and their activities in and outside of school. Taken together,
Study Design and Statistical Analysis
Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing
Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children
Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
Preventing Pediatric Diabetes: Are Racial Disparities A Factor? A Children s Health Fund Issue Brief February 2004
Preventing Pediatric Diabetes: Are Racial Disparities A Factor? A Children s Health Fund Issue Brief February 2004 The Children s Health Fund The Children s Health Fund (CHF), working with hospitals and
Fact sheet: UK 2-18 years Growth Chart
Fact sheet: UK 2-18 years Growth Chart This chart will most commonly be used for the assessment of individual children, rather than for population growth monitoring purposes and includes a number of new
Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER
Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER 80% of children and adults with FA have an endocrine abnormality Endocrine cells make a hormone (message) Carried in bloodstream
ALPHA (TNFa) IN OBESITY
THE ROLE OF TUMOUR NECROSIS FACTOR ALPHA (TNFa) IN OBESITY Alison Mary Morris, B.Sc (Hons) A thesis submitted to Adelaide University for the degree of Doctor of Philosophy Department of Physiology Adelaide
Diabetes. Prevalence. in New York State
Adult Diabetes Prevalence in New York State Diabetes Prevention and Control Program Bureau of Chronic Disease Evaluation and Research New York State Department of Health Authors: Bureau of Chronic Disease
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
Overweight and Obesity in Nevada. Overweight and Obesity in Nevada. Public Health Issue. Overview. Background BRFSS. Objective 9/5/2013
Overweight and Obesity in Nevada Overweight and Obesity in Nevada A Comparison of Behavioral Risk Factor Surveillance System and Department of Motor Vehicles Data Department of Health and Human Services
Prevention Status Report 2013
The Prevention Status Reports (PSRs) highlight for all 50 states and the District of Columbia the status of public health policies and practices designed to prevent or reduce important health problems.
DR. Trinh Thi Kim Hue
TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
Vitamin D Status: United States, 2001 2006
Vitamin D Status: United States, 2001 2006 Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.; Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos,
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
How To Know Your Health
Interpreting fitnessgram Results FITNESSGRAM uses criterion-referenced standards to evaluate fitness performance. These standards have been established to represent a level of fitness that offers some
The South Asian Indian Women s s Weight Loss Study. Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005
The South Asian Indian Women s s Weight Loss Study Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005 South Asian Emigrants and second generation from India Bhutan Bangladesh Maldives Nepal Pakistan
Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
Recent studies have demonstrated a relationship of
Type 2 Diabetes and Low Birth We i g h t The Role of Paternal Inheritance in the Association of Low Birth Weight and Diabetes Robert S. Lindsay, Dana Dabelea, Janine Roumain, Robert L. Hanson, Peter H.
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and
tips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:
tips Top International Publications Selection Insulin Pump Users Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated Patients with TD Population Study of Pediatric
Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance
Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance Dr Sarah Steven Clinical Research Fellow to Professor Roy Taylor Observations from bariatric surgery
Texas Diabetes Fact Sheet
I. Adult Prediabetes Prevalence, 2009 According to the 2009 Behavioral Risk Factor Surveillance System (BRFSS) survey, 984,142 persons aged eighteen years and older in Texas (5.4% of this age group) have
Practical Applications of Insulin Pump Therapy in Type 2 Diabetes
Practical Applications of Insulin Pump Therapy in Type 2 Diabetes Wendy Lane, MD For a CME/CEU version of this article please go to www.namcp.org/cmeonline.htm, and then click the activity title. Summary
It s just puppy fat Tackling obesity in children and adolescents
It s just puppy fat Tackling obesity in children and adolescents Webinar, SPH, Usyd, September 2013 Louise A Baur University of Sydney: Discipline of Paediatrics & Child Health, Sydney Medical School,
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype
Diagnosis, classification and prevention of diabetes
Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3
Statins and Risk for Diabetes Mellitus. Background
Statins and Risk for Diabetes Mellitus Kevin C. Maki, PhD, FNLA Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL 1 Background In 2012 the US Food and Drug Administration
Type 2 Diabetes in Youth A Road Less Travelled
Type 2 Diabetes in Youth A Road Less Travelled Julie Halipchuk, RN MN CDE Clinical Nurse Specialist Diabetes Education Resource for Children & Adolescents, Winnipeg, MB Objectives Discuss current trends
Racial and ethnic disparities in type 2 diabetes
Racial and ethnic disparities in type 2 diabetes Nisa M. Maruthur, MD, MHS Assistant Professor of Medicine & Epidemiology Welch Center for Prevention, Epidemiology, & Clinical Research The Johns Hopkins
Client Sex Facility Birth Date Height Weight Measured Sample Client Male (not specified) 00/00/0000 72.0 in. 180.0 lbs. 02/20/2016
SUMMARY RESULTS This table provides an overview of your total body composition, broken down into total body fat %, total mass, fat tissue, lean tissue, and bone mineral content. These metrics establish
Type 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
Roux-en-Y gastric bypass surgery converts two alcoholic drinks to four
Roux-en-Y gastric bypass surgery converts two alcoholic drinks to four Marta Yanina Pepino PhD 1, Adewole L. Okunade PhD 1, Christopher Eagon MD 1, Bruce D. Bartholow PhD 3, Kathleen Bucholz PhD, MPH,
Racial Disparities in US Healthcare
Racial Disparities in US Healthcare Paul H. Johnson, Jr. Ph.D. Candidate University of Wisconsin Madison School of Business Research partially funded by the National Institute of Mental Health: Ruth L.
ARE FLORIDA'S CHILDREN BORN HEALTHY AND DO THEY HAVE HEALTH INSURANCE?
infant mortality rate per 1,000 live births ARE FLORIDA'S CHILDREN BORN HEALTHY AND DO THEY HAVE HEALTH INSURANCE? Too Many of Florida's Babies Die at Birth, Particularly African American Infants In the
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.
Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels Take a moment Confer with your neighbour And try to solve the following word
Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
Updates in Insulin Injection Technique: Data and Recommendations
Updates in Insulin Injection Technique: Data and Recommendations Maureen Mo Bressett, RPh, MSHA Senior Medical Science Liaison BD Medical Affairs: Diabetes Care Disclosures Maureen Bressett is an employee
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005. Tania Tang PHASE Symposium May 12, 2007
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005 Tania Tang PHASE Symposium May 12, 2007 Presentation Outline Background Research Questions Methods Results Discussion
Diabetes: The Numbers
Diabetes: The Numbers Changing the Way Diabetes is Treated. What is Diabetes? Diabetes is a group of diseases characterized by high levels of blood glucose (blood sugar) Diabetes can lead to serious health
Humulin (LY041001) Page 1 of 1
(LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or
Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology
Sedentarity and Exercise in the Canadian Population Angelo Tremblay Division of kinesiology Disclosure of Potential Conflicts of Interest Évolution de la pratique d activité physique des adultes canadiens
Overweight, Obesity, and Diabetes in North Carolina
Overweight, Obesity, and Diabetes in North Carolina Overweight, obesity, and diabetes are among the most costly and harmful health problems in North Carolina. Moreover, the rates of overweight, obesity,
Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,
Objectives. What is undernutrition? What is undernutrition? What does undernutrition look like?
Objectives Basics Jean-Pierre Habicht, MD, PhD Professor Division of Nutritional Sciences Cornell University Types and causes Determinants Consequences Global occurrence and progress Way forward What is
Kansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
Baskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
Prevention of type 2 diabetes in young people: a theoretical perspective
Pediatric Diabetes 2003: 4: 38-56 Copyright # Blackwell Munksgaard 2003 Printed in Denmark. All rights reserved Pediatric Diabetes ISSN 1399-543X Review Article Prevention of type 2 diabetes in young people:
Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c
Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c Name: Period: Date: Part A Background The Pancreas and Insulin The following background information has been provided
PERINATAL NUTRITION. Nutrition during pregnancy and lactation. Nutrition during infancy.
PERINATAL NUTRITION Nutrition during pregnancy and lactation Nutrition during infancy. Rama Bhat, MD. Department of Pediatrics, University of Illinois Hospital Chicago, Illinois. Nutrition During Pregnancy
Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
The relationship between socioeconomic status and healthy behaviors: A mediational analysis. Jenn Risch Ashley Papoy.
Running head: SOCIOECONOMIC STATUS AND HEALTHY BEHAVIORS The relationship between socioeconomic status and healthy behaviors: A mediational analysis Jenn Risch Ashley Papoy Hanover College Prior research
Overview of the CDC Growth Charts
CDC: Safer - Healthier - People ~ 1 Overview of the CDC Growth Charts INTRODUCTION Childhood growth depends on nutritional, health, and environmental conditions. Changes in any of these influence how well
Healthy Aging Lab: Current Research Abstracts
Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic
Insulin Analogues versus Pump Therapy in Type 2 Diabetes: Benefits from Pump Therapy
Insulin Analogues versus Pump Therapy in Type 2 Diabetes: Benefits from Pump Therapy Eric RENARD, MD, PhD Endocrinology Dept, Lapeyronie Hospital Montpellier, France [email protected] Type 2
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
Appendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
